Notice2021-14259
Approvals and Denials of Test Marketing Exemptions for Certain New Chemicals Under TSCA
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 6, 2021
Issuing agencies
Environmental Protection Agency
Abstract
This document provides notification of EPA's approvals and denials of applications for test marketing exemptions (TMEs) submitted under the Toxic Substances Control Act (TSCA) for certain new chemicals. The test marketing conditions are described in the TME applications and in this document.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 126 (Tuesday, July 6, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 126 (Tuesday, July 6, 2021)]
[Notices]
[Pages 35499-35504]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-14259]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2019-0578; FRL-10004-31]
Approvals and Denials of Test Marketing Exemptions for Certain
New Chemicals Under TSCA
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This document provides notification of EPA's approvals and
denials of applications for test marketing exemptions (TMEs) submitted
under the Toxic Substances Control Act (TSCA) for certain new
chemicals. The test marketing conditions are described in the TME
applications and in this document.
FOR FURTHER INFORMATION CONTACT: For technical information contact: Meg
Victor, New Chemicals Division (7405M), Office of Pollution Prevention
and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460-0001; telephone number: (202) 343-9193; email
address: <a href="/cdn-cgi/l/email-protection#7b0d12180f140955161e1c3b1e0b1a551c140d"><span class="__cf_email__" data-cfemail="2d5b444e59425f0340484a6d485d4c034a425b">[email protected]</span></a>.
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: <a href="/cdn-cgi/l/email-protection#efbbbcacaec2a7809b8386818aaf8a9f8ec1888099"><span class="__cf_email__" data-cfemail="37636474761a7f58435b5e59527752475619505841">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action may be of interest to the chemical manufacturers and/or
importers who submitted the TMEs to EPA and to the public in general.
The Agency has not attempted to describe all the specific entities that
may be affected by this action.
B. How can I get copies of this document and other related information?
The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPPT-2019-0578, is available at <a href="http://www.regulations.gov">http://www.regulations.gov</a> or at the Office of Pollution Prevention and Toxics
Docket (OPPT Docket), Environmental Protection Agency Docket Center
(EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202)
566-1744, and the telephone number for the OPPT Docket is (202) 566-
0280.
Please note that due to the public health emergency the EPA Docket
Center (EPA/DC) and Reading Room was closed to public visitors on March
31, 2020. Our EPA/DC staff will continue to provide customer service
via email, phone, and webform. For further information on EPA/DC
services, docket contact information and the current status of the EPA/
DC and Reading Room, please visit <a href="https://www.epa.gov/dockets">https://www.epa.gov/dockets</a>.
II. What is the Agency's authority for taking this action?
TSCA section 5(h)(1) authorizes EPA to exempt persons from
premanufacture notification (PMN) requirements and permit them to
manufacture (which includes import) new chemicals for test marketing
purposes, if the Agency finds that the manufacture, processing,
distribution in commerce, use, and disposal of the chemicals for test
marketing purposes will not present any unreasonable risk of injury to
health or the environment, including an unreasonable risk to a
potentially exposed or susceptible subpopulation identified by the
Administrator for the specific conditions of use identified in the
applications. The requirement to consider risks to a potentially
exposed or susceptible subpopulation was added to TSCA section 5(h)(1)
in 2016. EPA's regulations implementing TSCA section 5(h)(1) are found
at 40 CFR 720.38.
TSCA section 5(h)(6) requires EPA to publish in the Federal
Register notice of receipt of an application for a TME and of the
disposition of the application. The implementing regulation (40 CFR
720.38(d)) indicates that EPA will publish a notice in the Federal
Register explaining the reasons for approval or denial.
III. What action is the Agency taking?
EPA is publishing this document to announce TME approvals and
denials. EPA determined that test marketing the new chemicals, under
the conditions in the TME applications, will not present any
unreasonable risk of injury to health or the environment; the Agency
approved the TMEs listed in Unit IV. For those TMEs for which EPA made
this approval after TSCA was amended in June 2016 by the Lautenberg
Chemical Safety for the 21st Century Act, EPA's determination included
an assessment of unreasonable risk to a potentially exposed or
susceptible subpopulation identified by the Agency for the specific
conditions of use identified in the applications.
EPA has denied the following TMEs because EPA was unable to
determine that test marketing the new chemicals, under the conditions
in the TME applications will not present any unreasonable risk of
injury to health or the environment. For those TMEs for which EPA made
this denial after TSCA was amended in June 2016, EPA's determination
included an assessment of unreasonable risk to a potentially exposed or
susceptible subpopulation identified by the Agency for the specific
conditions of use identified in the applications.
TME-13-0004
Date of Receipt: November 26, 2012.
Notice of Receipt: December 26, 2012 (77 FR 76029; FRL-9373-1).
TME-13-0091
Date of Receipt: August 22, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
TME-16-0004
Date of Receipt: November 3, 2015.
Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
TME-16-0005
Date of Receipt: November 3, 2015.
Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
TME-16-0013
Date of Receipt: December 15, 2015.
Notice of Receipt: February 11, 2016 (81 FR 7337; FRL-9942-09).
TME-16-0014
Date of Receipt: December 15, 2015.
Notice of Receipt: February 11, 2016 (81 FR 7337; FRL-9942-09).
TME-16-0015
Date of Receipt: December 15, 2015.
Notice of Receipt: February 11, 2016 (81 FR 7337; FRL-9942-09).
TME-17-0002
Date of Receipt: November 17, 2016.
Notice of Receipt: N/A.
TME-17-0003
Date of Receipt: April 5, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0004
Date of Receipt: April 5, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
[[Page 35500]]
TME-17-0005
Date of Receipt: April 5, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0006
Date of Receipt: April 5, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0007
Date of Receipt: April 5, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0008
Date of Receipt: April 5, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0009
Date of Receipt: April 13, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0010
Date of Receipt: April 13, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0011
Date of Receipt: April 13, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0012
Date of Receipt: April 19, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-17-0013
Date of Receipt: April 19, 2017.
Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).
TME-18-0002
Date of Receipt: January 26, 2018.
Notice of Receipt: May 24, 2018 (83 FR 24110; FRL-9977-48).
IV. What restrictions apply to the approved TMEs?
The test market time period, production volume, number of
customers, and use must not exceed specifications in the applications.
All other conditions and restrictions described in the applications and
in this document must also be met.
TME-12-0009
Date of Receipt: April 18, 2012.
Notice of Receipt: N/A.
Applicant: CBI.
Chemical: (Generic) Alkyl thiol, manuf. of, by-products from,
distn. lights.
Use: (Generic) Intermediate in the production of a commercial
product.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-12-0010
Date of Receipt: April 18, 2012.
Notice of Receipt: N/A.
Applicant: CBI.
Chemical: (Generic) alkyl thiol, manuf. of, by-products from,
distn. lights.
Use: (Generic) Intermediate in the production of a commercial
product.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-12-0014
Date of Receipt: August 27, 2012.
Notice of Receipt: October 10, 2012 (77 FR 61600; FRL-9363-2).
Applicant: Cytec Industries, Inc.
Chemical: (Generic) Substituted heteromonocycle, polymer with
substituted alkane and substituted alkanediol, alkanoic acid
substituted ester and substituted heteromonocyle homopolymer.
Use: Coating resin.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: Forty-five days, commencing on first day of
commercial manufacture.
TME-13-0001
Date of Receipt: October 22, 2012.
Notice of Receipt: December 14, 2012 (77 FR 74473; FRL-9338-5).
Applicant: Cytec Industries, Inc.
Chemical: (Generic) Alkenoic acid, ester with alkylpolyol, polymer
with disubstituted alkane.
Use: (Generic) Coating resin.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: Forty-five days, commencing on first day of
commercial manufacture.
TME-13-0002
Date of Receipt: November 1, 2012.
Notice of Receipt: December 26, 2012 (77 FR 76029; FRL-9373-1).
Applicant: Cytec Industries, Inc.
Chemical: (Generic) Alkenenitrile, polymer with alkadiene,
substituted alkyl-terminated, polymers with substituted
carbonomocycles, alkoxy-terminated-substituted alkyl-alkadiene polymer,
substituted carbomonocycle and halogen substituted carbomonocycle.
Use: (Generic) Resin for non-dispersive use.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: Forty-five days, commencing on first day of
commercial manufacture.
TME-13-0003
Date of Receipt: November 12, 2012.
Notice of Receipt: December 26, 2012 (77 FR 76029; FRL-9373-1).
Applicant: Cytec Industries, Inc.
Chemical: (Generic) Alkenoic acid, reaction product with
alkylpolyol, polymers with substituted heteromonocycle.
Use: (Generic) Coating resin.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: Forty-five days, commencing on first day of
commercial manufacture.
TME-13-0007
Date of Receipt: January 31, 2013.
Notice of Receipt: March 22, 2013 (78 FR 17656; FRL-9380-1).
Applicant: H.B. Fuller Company.
Chemical: (Generic) Fatty acids, C18-unsatd., dimers, polymers with
alkane acid, 1,6-hexanediol, 1,1'-methylenebis[4-isocyanatobenzene] and
neopentyl glycol.
Use: (Generic) Industrial adhesive.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0008
Date of Receipt: February 19, 2013.
Notice of Receipt: May 15, 2013 (78 FR 28586; FRL-9383-9).
Applicant: Cytec Industries, Inc.
Chemical: (Generic) Alkenoic acid, polymer with alkadiene and
alkenenitrile, substituted alkyl-terminated, polymers with substituted
carbomonocycles, alkoxy-terminated-substituted alkyl-alkadiene polymer,
substituted carbomonocycle and halogen substituted carbomonocycle.
Use: (Generic) Resin for non-dispersive uses.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: Forty-five days, commencing on first day of
commercial manufacture.
TME-13-0009
Date of Receipt: February 19, 2013.
Notice of Receipt: May 15, 2013 (78 FR 28586; FRL-9383-9).
Applicant: CBI.
Chemical: (Generic) Furandione derivative reaction products.
Use: (Generic) Production aid in refinery operations.
[[Page 35501]]
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0010
Date of Receipt: May 6, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Alpha-olefins, polymers with maleic anhydride,
alkyl esters.
Use: (Generic) Crude oil additive.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0053
Date of Receipt: August 14, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Amine capped fatty acid dimer polyamide.
Use: (Generic) Component in drilling fluids; (Generic) Component in
resin coatings.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0054
Date of Receipt: August 7, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid
salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0055
Date of Receipt: August 7, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid
salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0056
Date of Receipt: August 7, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid
salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0057
Date of Receipt: August 7, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid
salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0058
Date of Receipt: August 7, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid
salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0059
Date of Receipt: August 7, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid
salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0060
Date of Receipt: August 12, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0061
Date of Receipt: August 12, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0062
Date of Receipt: August 12, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0063
Date of Receipt: August 12, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0064
Date of Receipt: August 12, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-13-0065
Date of Receipt: August 12, 2013.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
[[Page 35502]]
Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
Use: (Generic) Inhibitor for oil field applications.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-14-0002
Date of Receipt: January 10, 2014.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Modified essential oil.
Use: (Generic) Highly dispersive use.
Production Volume: CBI.
Number of Customers: CBI
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-14-0003
Date of Receipt: March 7, 2014.
Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
Applicant: CBI.
Chemical: (Generic) Substituted acid, electrophilic aromatic
substitution products.
Use: (Generic) Foam suppressant.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-14-0004
Date of Receipt: July 3, 2014.
Notice of Receipt: N/A.
Applicant: Clean Chemistry.
Chemical: (Generic) Organic peroxide.
Use: Water clarifying agent, odor control agent, bleaching agent,
and general oxidant for water treatment; (Generic) Destructive use in
fuel production.
Production Volume: CBI.
Number of Customers: Six.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0001
Date of Receipt: November 21, 2014.
Notice of Receipt: N/A.
Applicant: Industrial Specialty Chemicals.
Chemical: CBI.
Use: Paint detackification.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0004
Date of Receipt: January 8, 2015.
Notice of Receipt: March 19, 2015 (80 FR 14374; FRL-9924-61).
Applicant: CBI.
Chemical: (Generic) Alkylaminopropanamide, N-[dialkylamino-propyl],
salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0005
Date of Receipt: January 8, 2015.
Notice of Receipt: March 19, 2015 (80 FR 14374; FRL-9924-61).
Applicant: CBI.
Chemical: (Generic) Alkylaminopropanamide, N-[dialkylamino-propyl],
salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0006
Date of Receipt: January 8, 2015.
Notice of Receipt: March 19, 2015 (80 FR 14374; FRL-9924-61).
Applicant: CBI.
Chemical: (Generic) Alkylaminopropanamide, N-[dialkylamino-propyl],
salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0007
Date of Receipt: January 8, 2015.
Notice of Receipt: March 19, 2015 (80 FR 14374; FRL-9924-61).
Applicant: CBI.
Chemical: (Generic) Alkylaminopropanamide, N-[dialkylamino-propyl],
salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0008
Date of Receipt: March 20, 2015.
Notice of Receipt: April 22, 2015 (80 FR 22512; FRL-9926-36).
Applicant: CBI.
Chemical: (Generic) Alkyl substituted cresol.
Use: (Generic) Intermediate.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0011
Date of Receipt: June 24, 2015.
Notice of Receipt: August 14, 2015 (80 FR 48855; FRL-9931-82).
Applicant: CBI.
Chemical: (Generic) Dialkylamino alkylamide salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0012
Date of Receipt: June 24, 2015.
Notice of Receipt: August 14, 2015 (80 FR 48855; FRL-9931-82).
Applicant: CBI.
Chemical: (Generic) Dialkylamino alkylamide salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0013
Date of Receipt: June 24, 2015.
Notice of Receipt: August 14, 2015 (80 FR 48855; FRL-9931-82).
Applicant: CBI.
Chemical: (Generic) Dialkylamino alkylamide salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-15-0014
Date of Receipt: June 24, 2015.
Notice of Receipt: August 14, 2015 (80 FR 48855; FRL-9931-82).
Applicant: CBI.
Chemical: (Generic) Dialkylamino alkylamide salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0001
Date of Receipt: November 2, 2015.
Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
Applicant: CBI.
Chemical: (Generic) Dialkylamino alkylamide salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
[[Page 35503]]
TME-16-0002
Date of Receipt: November 2, 2015.
Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
Applicant: CBI.
Chemical: (Generic) Dialkylamino alkylamide salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0003
Date of Receipt: November 3, 2015.
Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
Applicant: CBI.
Chemical: (Generic) Beta amino fatty ester.
Use: Chemical Intermediate.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0006
Date of Receipt: November 3, 2015.
Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
Applicant: CBI.
Chemical: (Generic) Dialkylamino alkylamide.
Use: Chemical Intermediate.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0007
Date of Receipt: November 10, 2015.
Notice of Receipt: N/A.
Applicant: CBI.
Chemical: (Generic) Poly alkylimidazoline.
Use: (Generic) Emulsifier.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0008
Date of Receipt: November 10, 2015.
Notice of Receipt: N/A.
Applicant: CBI.
Chemical: (Generic) Poly alkylimidazoline.
Use: (Generic) Emulsifier.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0009
Date of Receipt: November 10, 2015.
Notice of Receipt: N/A.
Applicant: CBI.
Chemical: (Generic) Poly alkylimidazoline.
Use: (Generic) Emulsifier.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0010
Date of Receipt: November 10, 2015.
Notice of Receipt: N/A.
Applicant: CBI.
Chemical: (Generic) Poly alkylimidazoline.
Use: (Generic) Emulsifier.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0011
Date of Receipt: November 10, 2015.
Notice of Receipt: N/A.
Applicant: CBI.
Chemical: (Generic) Poly alkylimidazoline.
Use: (Generic) Emulsifier.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0012
Date of Receipt: November 10, 2015.
Notice of Receipt: N/A.
Applicant: CBI.
Chemical: (Generic) Poly alkylimidazoline.
Use: (Generic) Emulsifier.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0016
Date of Receipt: December 16, 2015.
Notice of Receipt: February 11, 2016 (81 FR 7337; FRL-9942-09).
Applicant: CBI.
Chemical: (Generic) Dialkylamino alkylamide inner salt.
Use: (Generic) Oil production.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-16-0017
Date of Receipt: May 25, 2016.
Notice of Receipt: July 29, 2016 (81 FR 49976; FRL-9949-63) and
September 6, 2017 (82 FR 42088; FRL-9965-05).
Applicant: CBI.
Chemical: (Generic) Modified vegetable oil.
Use: (Generic) Wax.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-18-0001
Date of Receipt: November 16, 2017.
Notice of Receipt: May 22, 2018 (83 FR 23671; FRL-9972-08).
Applicant: CBI.
Chemical: (Generic) Renewable naptha.
Use: Component in automotive gasoline/transportation fuel for
consumer use.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
TME-18-0003
Date of Receipt: July 17, 2018.
Notice of Receipt: October 22, 2018 (83 FR 53241; FRL-9985-20).
Applicant: CBI.
Chemical: (Generic) Alkylated diphenylamines, homopolymers.
Use: (Generic) Additive.
Production Volume: CBI.
Number of Customers: CBI.
Test Marketing Period: CBI days, commencing on first day of
commercial manufacture.
EPA may impose restrictions considered appropriate by the Agency on
test marketing activities and may modify or revoke this test marketing
exemption upon receipt of any information that indicates the test
marketing activity may present an unreasonable risk of injury to health
and the environment. The following additional restrictions apply to
these TMEs: A bill of lading accompanying each shipment must state that
the use of the chemical is restricted to that approved in the TME. In
addition, the applicant shall maintain the following records for 5
years after the date they are created, and shall make them available
for inspection or copying in accordance with TSCA section 11:
1. Records of the quantity of the TME chemical produced and the
date of manufacture.
2. Records of dates of the shipments to each customer and the
quantities supplied in each shipment.
3. Copies of the bill of lading that accompanies each shipment of
the TME chemical.
[[Page 35504]]
V. What was EPA's risk assessment for these approved TMEs?
EPA did not identify unreasonable health or environmental risks for
the test market chemicals under the intended conditions of use
described in the TME applications. Therefore, the test market
activities will not present any unreasonable risk of injury to human
health or the environment, including an unreasonable risk to a
potentially exposed or susceptible subpopulation identified by the
Administrator for the specific conditions of use identified in the
applications.
VI. Can EPA change its decision on these approved TMEs in the future?
The Agency reserves the right to rescind approval or modify the
conditions and restrictions of an exemption upon the receipt or
evaluation of any information, new or existing, that indicates the test
marketing activities may present an unreasonable risk of injury to
human health or the environment.
Authority: 15 U.S.C. 2601 et seq.
Dated: June 11, 2021.
Madison Le,
Director, New Chemicals Division, Office of Pollution Prevention and
Toxics.
[FR Doc. 2021-14259 Filed 7-2-21; 8:45 am]
BILLING CODE 6560-50-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 6, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.